Anti-psychotic
medications, often known as tranquillizers or neuroleptics, are a class of
medication commonly used to treat schizophrenia and bipolar illness. They're
used to treat psychosis, which includes hallucinations, delusions, and paranoid
thoughts, among other things. Antipsychotic medications are successful in
treating psychosis in a short period of time. These medications inhibit the
action of dopamine, which is directly connected to psychotic symptoms, by
blocking dopamine receptors in the brain's dopaminergic pathways. Antipsychotic
use has increased as the prevalence of mental disorder has increased. According
to the National Alliance of Mental Illness, one in every five adults suffers
from mental illness, accounting for 18.5 percent of the overall population.
Long-term use of these medications, on the other hand, may cause adverse
effects such metabolic syndrome and involuntary movement disorder, leading to
an increase in mortality in the older population with dementia.
Overview of the
Global Antipsychotic Drugs Market
Because of
the global growth in prevalence of psychotic diseases such as bipolar disorder,
schizophrenia, delusions, hallucinations, and very severe depression (known as
"psychotic depression"), the global
Antipsychotic Drugs Market
medications is gaining traction. According to recent studies,
antipsychotics are one of the most popular and extensively prescribed
medications in the United States for the treatment of psychotic disorders.
Drivers of the Global
Antipsychotic Drugs Market
The rising
frequency of Schizophrenia and psychotic diseases is a primary driver of the
worldwide anti-psychotic medications industry. Several other causes, such as
rising drug abuse rates, overprescription of psychotic medicines, and
antipsychotic drug addiction, also contribute to market expansion. According to
the National Survey on Substance Use and Health (NSDUH), in 2012, 13.2 percent
of the US population (almost 4 million people) used an illegal drug or misused
a psychotherapeutic medication. However, the recent patent expiration of key
brands has had a detrimental impact on market growth. Furthermore,
anti-psychotics' side effects, which include tardive dyskinesia, sleeplessness,
and a variety of other problems, are limiting the worldwide anti-psychotic
medications market's growth.
Comments
Post a Comment